QQQ   416.28 (-1.68%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.28 (-1.68%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.28 (-1.68%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.28 (-1.68%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
Free Trial
OTCMKTS:CUBT

Curative Biotechnology (CUBT) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free CUBT Stock Alerts
$0.02
0.00 (-10.04%)
(As of 04/18/2024 05:33 PM ET)
Compare
Today's Range
$0.02
▼
$0.03
50-Day Range
$0.02
▼
$0.04
52-Week Range
$0.01
▼
$0.04
Volume
98,708 shs
Average Volume
204,658 shs
Market Capitalization
$17.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsSEC FilingsShort Interest
CUBT stock logo

About Curative Biotechnology Stock (OTCMKTS:CUBT)

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

CUBT Stock Price History

CUBT Stock News Headlines

April 11, 2024 | americanbankingnews.com
Short Interest in Curative Biotechnology, Inc. (OTCMKTS:CUBT) Rises By 175.0%
March 31, 2024 | globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 29, 2024 | seekingalpha.com
SFRX Seafarer Exploration Corp.
March 22, 2024 | globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
January 22, 2024 | insidermonkey.com
Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?
October 31, 2023 | finanznachrichten.de
Curative Biotechnology, Inc.?: Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
August 18, 2023 | thestreet.com
3 Best Biotech Stocks to Add to Your Portfolio
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
June 6, 2023 | finance.yahoo.com
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
June 2, 2023 | bizjournals.com
Sacramento Biotech News
May 24, 2023 | finance.yahoo.com
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
January 5, 2023 | finanznachrichten.de
Curative Biotechnology, Inc.?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
November 12, 2022 | finance.yahoo.com
Curative Biotechnology, Inc. (CUBT)
November 8, 2022 | seekingalpha.com
Curative Biotechnology refiles for NYSE uplisting, $8M offering
October 20, 2022 | finanznachrichten.de
Curative Biotechnology, Inc.: Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
September 30, 2022 | seekingalpha.com
Curative Biotechnology files for NYSE American uplisting, $8M IPO
September 26, 2022 | benzinga.com
Curative Biotechnology Stock (OTC:CUBT), Short Interest Report
September 22, 2022 | seekingalpha.com
CUBT Curative Biotechnology, Inc.
June 16, 2022 | finance.yahoo.com
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
May 12, 2022 | finance.yahoo.com
Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors
May 12, 2022 | finance.yahoo.com
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors
May 4, 2022 | yahoo.com
Can You Pay a Mortgage With a Credit Card?
May 3, 2022 | finance.yahoo.com
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
May 3, 2022 | finance.yahoo.com
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration
March 21, 2022 | seekingalpha.com
Curative signs agreement with NEI to develop age-related eye disease treatment
March 21, 2022 | morningstar.com
Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator
See More Headlines
Receive CUBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CUBT
CUSIP
N/A
CIK
1400271
Web
curativebiotech.com
Phone
(561) 418-7725
Fax
866-900-1002
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
703,260,000
Free Float
N/A
Market Cap
$17.02 million
Optionable
Not Optionable
Beta
-17.73
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Paul M. Michael
    Executive Chairman & President
  • I. Richard Garr
    Chief Executive Officer & General Counsel
  • Ron Bordens
    Executive VP-Technical Operations & Manufacturing
  • Barry A. Ginsberg
    Vice Chairman & Chief Strategy Officer

Key Competitors

View All Competitors

CUBT Stock Analysis - Frequently Asked Questions

How have CUBT shares performed in 2024?

Curative Biotechnology's stock was trading at $0.0213 at the start of the year. Since then, CUBT stock has increased by 13.6% and is now trading at $0.0242.
View the best growth stocks for 2024 here.

Are investors shorting Curative Biotechnology?

Curative Biotechnology saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,300 shares, an increase of 175.0% from the March 15th total of 1,200 shares. Based on an average daily trading volume, of 91,400 shares, the days-to-cover ratio is currently 0.0 days.
View Curative Biotechnology's Short Interest.

When is Curative Biotechnology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our CUBT earnings forecast.

How do I buy shares of Curative Biotechnology?

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CUBT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
1970’s computer coder issues shocking A.I. warning
TradeSmith
SHOCKING Crypto Leak…
Crypto 101 Media